Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma - Aix-Marseille Université Access content directly
Journal Articles Neuro-Oncology Year : 2018

Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

David Ellingson
  • Function : Author
Lauren Abrey
  • Function : Author
Sarah Nelson
  • Function : Author
Timothy Kaufmann
  • Function : Author
Josep Garcia
  • Function : Author
Olivier Chinot
Frank Saran
  • Function : Author
Ryo Nishikawa
  • Function : Author
Warren Mason
  • Function : Author
Wolfgang Wick
Nicholas Butowski
  • Function : Author
Howard Colman
  • Function : Author
John de Groot
  • Function : Author
Susan Chang
  • Function : Author
Ingo Mellinghoff
  • Function : Author
Brian Alexander
  • Function : Author
Rivka Colen
  • Function : Author
Jennie Taylor
  • Function : Author
Isabel Arrillaga-Romany
  • Function : Author
David Mehta
  • Function : Author
Raymond Huang
  • Function : Author
David Reardon
  • Function : Author
Michael Prados
  • Function : Author
Evanthia Galanis
  • Function : Author
  • PersonId : 942136
Patrick Wen
  • Function : Author
Timothy Cloughesy
  • Function : Author

Dates and versions

hal-01814367 , version 1 (13-06-2018)

Identifiers

Cite

David Ellingson, Lauren Abrey, Sarah Nelson, Timothy Kaufmann, Josep Garcia, et al.. Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro-Oncology, 2018, ⟨10.1093/neuonc/noy053⟩. ⟨hal-01814367⟩
20 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More